Serum osteoprotegerin and its ligand in cirrhotic patients referred for orthotopic liver transplantation: relationship with metabolic bone disease
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Aims: A prospective study was carried out in 22 cirrhotic patients referred for orthotopic liver transplantation, in order to analyze serum osteoprotegerin (OPG) and RANKL levels and their relationship with metabolic bone disease. Methods: Serum levels of OPG and RANKL were measured in all patients as well as bone markers, serum parathyroid hormone and 25‐hydroxyvitamin D levels. OPG and RANKL values were compared with those obtained in 29 healthy controls. Bone mineral density (BMD) of the lumbar spine and proximal femur was measured by dual X‐ray absorptiometry and spinal X‐rays were obtained to assess vertebral fractures. Results: Serum OPG levels were higher in cirrhotic patients than in controls (6.4±2 vs 2.7±0.7 pmol/l; P=0.001) and RANKL serum levels were lower in cirrhotic patients (0.215±0.6 vs 1.012±1.2 pmol/l; P=0.002), with an increased OPG:RANKL ratio when compared with the control group (280.3±334.5 vs 113±137.6; P=0.04). Ten patients had osteoporosis (45%) and up to 45% skeletal fractures. No differences were found in OPG levels between patients with and without osteoporosis by densitometric criteria or fractures. Negative correlations were found between OPG levels and femoral neck (R−0.46; P=0.03) and total hip BMD (R−0.48; P=0.025). By contrast, OPG values were not related to markers of bone turnover. Conclusions: OPG values are elevated in cirrhotic patients before liver transplantation, particularly in those with low bone mass at the proximal femur.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology
Hofbauer, L. C., & Heufelder, A. E. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100226 · Cited by 586
Correlates of osteoprotegerin levels in women and men.
Khosla, S., Arrighi, H. M., Melton, III, Atkinson, E. J., O'Fallon, W. M., Dunstan, C., & Riggs, B. L. (2002) · Osteoporosis International · doi:10.1007/s001980200045 · Cited by 205 · cited 1×
“Moreover, it should be noted that in healthy and in osteoporotic postmenopausal populations the relationship between OPG serum levels and markers of bone turnover is somewhat inconclusive, showing indistinctly positive and negative associations (15, 16).”
BackgroundMonegal, A., Navasa, M., Guañabens, N., Peris, P., Pons, F., Martinez de Osaba, M. J., Ordi, J., Rimola, A., Rodés, J., & Muñoz-Gómez, J. (2001) · Osteoporosis International · doi:10.1007/s001980170094 · Cited by 183
Self-citationSoluble RANKL and risk of nontraumatic fracture.
Schett, G. (2004) · JAMA · doi:10.1001/jama.291.9.1108 · Cited by 146
Mezquita-Raya, P., de la Higuera, M., García, D. F., Alonso, G., Ruiz-Requena, M. E., de Dios Luna, J., Escobar-Jiménez, F., & Muñoz-Torres, M. (2005) · Osteoporosis International · doi:10.1007/s00198-005-1844-1 · Cited by 98 · cited 1×
“Moreover, it should be noted that in healthy and in osteoporotic postmenopausal populations the relationship between OPG serum levels and markers of bone turnover is somewhat inconclusive, showing indistinctly positive and negative associations (15, 16).”
BackgroundSerum osteoprotegerin and RANKL levels in chronic alcoholic liver disease
GARCÍA-VALDECASAS-CAMPELO, E., GONZÁLEZ-REIMERS, E., SANTOLARIA-FERNÁNDEZ, F., DE LA VEGA-PRIETO, M. J., MILENA-ABRIL, A., SÁNCHEZ-PÉREZ, M. J., MARTÍNEZ-RIERA, A., & GÓMEZ-RODRÍGUEZ, M. D. L. Á. (2006) · Alcohol and Alcoholism · doi:10.1093/alcalc/agl004 · Cited by 77
Fahrleitner, A., Prenner, G., Leb, G., Tscheliessnigg, K. H., Piswanger-Sölkner, C., Obermayer-Pietsch, B., Portugaller, H. R., Berghold, A., & Dobnig, H. (2003) · Bone · doi:10.1016/s8756-3282(02)00926-2 · Cited by 71
Cited by
Current understanding of osteoporosis associated with liver disease
Nakchbandi, I. A., & van der Merwe, S. W. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.166 · Cited by 98
Skeletal turnover, bone mineral density, and fractures in male chronic abusers of alcohol
Santori, C., Ceccanti, M., Diacinti, D., Attilia, M. L., Toppo, L., D’Erasmo, E., Romagnoli, E., Mascia, M. L., Cipriani, C., Prastaro, A., et al. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03346365 · Cited by 87
Bone microarchitecture and bone turnover in hepatic cirrhosis
Wakolbinger, R., Muschitz, C., Scheriau, G., Bodlaj, G., Kocijan, R., Feichtinger, X., Schanda, J. E., Haschka, J., Resch, H., & Pietschmann, P. (2019) · Osteoporosis International · doi:10.1007/s00198-019-04870-6 · Cited by 39
Moradi, M., Doustimotlagh, A. H., Dehpour, A. R., Rahimi, N., & Golestani, A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116706 · Cited by 9
Kuo, S.-J., Chen, C.-L., Chen, S.-H., & Ko, J.-Y. (2023) · Life · doi:10.3390/life13071438 · Cited by 7
Metadata
- Authors
- Monegal, A., Navasa, M., Peris, P., Alvarez, L., Pons, F., Rodés, J., & Guañabens, N.
- Venue
- Liver International
- Publisher
- Wiley
- Published
- 2007-02-19
- Volume
- 27
- Issue
- 4
- Pages
- 492-497
- ISSN
- 0106-9543 (ISSN-L)
- 1478-3223
- 1478-3231
- OpenAlex
- W2047662847
- Cited by
- 31
- References
- 7
- FWCI
- 0.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum osteoprotegerin and its ligand in cirrhotic patients referred for orthotopic liver transplantation: relationship with metabolic bone disease. https://app.cochat.ai/papers/10.1111/j.1478-3231.2007.01448.x
- The paper
- Monegal, A., Navasa, M., Peris, P., Alvarez, L., Pons, F., Rodés, J., & Guañabens, N. (2007). Serum osteoprotegerin and its ligand in cirrhotic patients referred for orthotopic liver transplantation: relationship with metabolic bone disease. Liver International. https://doi.org/10.1111/j.1478-3231.2007.01448.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.